Finance

Lists
Why is 688428 up 2,89%?
Dive Deeper
688428:SHA
InnoCare Pharma Limited
26,01 CN¥
+2,89%
(+0,73) 1D
16 қаз., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688428...
Open
25,68 CN¥
High
27,16 CN¥
Low
25,65 CN¥
Mkt. cap
22,20 млрд
Avg. vol.
12,76 млн
Volume
14,17 млн
P/E ratio
53,39
52-wk high
35,00 CN¥
52-wk low
19,36 CN¥
EPS
0,49 CN¥
No. of employees
1 мың
Open
25,68 CN¥
High
27,16 CN¥
Low
25,65 CN¥
Mkt. cap
22,20 млрд
Avg. vol.
12,76 млн
Volume
14,17 млн
P/E ratio
53,39
52-wk high
35,00 CN¥
52-wk low
19,36 CN¥
EPS
0,49 CN¥
No. of employees
1 мың
News stories
From web sources and news partners
About InnoCare Pharma Limited
CEOJasmine Cui
Employees1,39 мың
Founded2015 ж. 03 қар.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
383,89 млн
1,26 млрд
528,63 млн
608,43 млн
Cost of goods sold
48,46 млн
66,11 млн
62,72 млн
56,27 млн
Cost of revenue
48,46 млн
66,11 млн
62,72 млн
56,27 млн
Research and development expenses
226,35 млн
275,57 млн
229,16 млн
267,92 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187,93 млн
243,50 млн
162,45 млн
205,62 млн
Operating expense
388,22 млн
560,08 млн
392,10 млн
476,27 млн
Total operating expenses
436,68 млн
626,19 млн
454,82 млн
532,54 млн
Operating income
-52,79 млн
633,39 млн
73,81 млн
75,89 млн
Other non operating income
26,02 млн
-26,67 млн
11,13 млн
-13,40 млн
EBT including unusual items
-33,60 млн
719,92 млн
104,85 млн
142,30 млн
EBT excluding unusual items
-8,17 млн
673,62 млн
101,24 млн
102,50 млн
Income tax expense
2,72 млн
3,79 млн
2,40 млн
5,07 млн
Effective tax rate
-8,09%
0,53%
2,29%
3,57%
Other operating expenses
-25,90 млн
40,29 млн
-320,57 м.
3,37 млн
Net income
-34,32 млн
706,88 млн
105,82 млн
140,54 млн
Net profit margin
-8,94%
56,12%
20,02%
23,10%
Earnings per share
-
-
-
-
Interest and investment income
44,67 млн
47,46 млн
30,69 млн
37,25 млн
Interest expense
-14,49 млн
-12,42 млн
-14,38 млн
-15,13 млн
Net interest expenses
30,17 млн
35,04 млн
16,30 млн
22,12 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-36,03 млн
652,95 млн
93,37 млн
94,23 млн
Gain or loss from assets sale
3,40 мың
-3,40 мың
-
-197,23 м.
AI content may include mistakes. Learn more
Google қолданбалары